These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 7252421

  • 1. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H, Perlmann P, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1981 Jun 01; 153(6):1592-603. PubMed ID: 7252421
    [Abstract] [Full Text] [Related]

  • 2. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B, Perlmann H, Perlmann P, Schreiber RD, Müller-Eberhard HJ.
    J Immunol; 1983 Jun 01; 130(6):2831-6. PubMed ID: 6222118
    [Abstract] [Full Text] [Related]

  • 3. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD, Lambris JD.
    J Exp Med; 1982 Jan 01; 155(1):96-110. PubMed ID: 6915077
    [Abstract] [Full Text] [Related]

  • 4. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD, Newman SL, Lambris JD, Devery-Pocius JE, Cain JA, Lachmann PJ.
    J Exp Med; 1983 Aug 01; 158(2):334-52. PubMed ID: 6224880
    [Abstract] [Full Text] [Related]

  • 5. Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3).
    Newman SL, Devery-Pocius JE, Ross GD, Henson PM.
    Complement; 1984 Aug 01; 1(4):213-27. PubMed ID: 6242391
    [Abstract] [Full Text] [Related]

  • 6. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R, Myones BL, Barel M, Krikorian L, Charriaut C, Ross GD.
    Eur J Immunol; 1985 Dec 01; 15(12):1192-7. PubMed ID: 3878789
    [Abstract] [Full Text] [Related]

  • 7. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ, Tedder TF, Fearon DT.
    Proc Natl Acad Sci U S A; 1984 Feb 01; 81(3):881-5. PubMed ID: 6230668
    [Abstract] [Full Text] [Related]

  • 8. Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.
    Lambris JD, Dobson NJ, Ross GD.
    J Exp Med; 1980 Dec 01; 152(6):1625-44. PubMed ID: 6450259
    [Abstract] [Full Text] [Related]

  • 9. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG, Melamed J, Arnaout MA.
    Eur J Immunol; 1983 Jun 01; 13(6):465-70. PubMed ID: 6222909
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O, Hammann KP, Schmid HU, Schulz T, Alsenz J, Dierich MP.
    Int Arch Allergy Appl Immunol; 1982 Jun 01; 69(3):231-7. PubMed ID: 6215359
    [Abstract] [Full Text] [Related]

  • 12. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M, Mussel HH, Dierich MP.
    J Immunol; 1981 May 01; 126(5):2042-7. PubMed ID: 7217681
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
    Ramos OF, Sármay G, Klein E, Yefenof E, Gergely J.
    Proc Natl Acad Sci U S A; 1985 Aug 01; 82(16):5470-4. PubMed ID: 3895232
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E, Sim RB.
    Biochem J; 1981 Sep 15; 198(3):509-18. PubMed ID: 7326019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
    Arnaout MA, Todd RF, Dana N, Melamed J, Schlossman SF, Colten HR.
    J Clin Invest; 1983 Jul 15; 72(1):171-9. PubMed ID: 6874946
    [Abstract] [Full Text] [Related]

  • 19. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
    Erdei A, Benczur M, Fábry Z, Dierich MP, Gergely J.
    Scand J Immunol; 1984 Aug 15; 20(2):125-31. PubMed ID: 6236547
    [Abstract] [Full Text] [Related]

  • 20. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Lachmann PJ, Voak D, Oldroyd RG, Downie DM, Bevan PC.
    Vox Sang; 1983 Aug 15; 45(5):367-72. PubMed ID: 6605620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.